According to a new report by Polaris Market Research, the global Head and Neck Cancer Therapeutics market was valued at USD 2,041.07 million in 2025 and is projected to reach USD 5,701.07 million by 2034, expanding at a CAGR of 12.10% over the forecast period. Growth is underpinned by rising smoking and alcohol-related risk factors, expanding HPV infection rates, and accelerating...